1-3 of 3
Meyling Cheok
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study

Clinical Trials & Observations
Loïc Vasseur, Laurène Fenwarth, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Maël Heiblig, Pierre-Yves Dumas, Christian Récher, Céline Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling Cheok, Raphael Itzykson, Nicolas Duployez
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4024–4034.
https://doi.org/10.1182/bloodadvances.2023010155
Published: 2023
Includes: Supplemental data
Journal Articles

Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis

Florian Renosi, Anne Roggy, Ambre Giguelay, Lou Soret, Pierre-Julien Viailly, Meyling Cheok, Sabeha Biichle, Fanny Angelot-Delettre, Vahid Asnafi, Elizabeth Macintyre, Sandrine Geffroy, Mary Callanan, Tony Petrella, Eric Deconinck, Etienne Daguindau, Véronique Harrivel, Sabrina Bouyer, Véronique Salaun, Pascale Saussoy, Jean Feuillard, Pascal Fuseau, Philippe Saas, Olivier Adotévi, Fabrice Jardin, Christophe Ferrand, Claude Preudhomme, Jacques Colinge, Christophe Roumier, Francine Garnache-Ottou
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1540–1551.
https://doi.org/10.1182/bloodadvances.2020003359
Published: 2021
Includes: Supplemental data
Journal Articles

Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature

Clinical Trials & Observations
Ali Nehme, Hassan Dakik, Frédéric Picou, Meyling Cheok, Claude Preudhomme, Hervé Dombret, Juliette Lambert, Emmanuel Gyan, Arnaud Pigneux, Christian Récher, Marie C. Béné, Fabrice Gouilleux, Kazem Zibara, Olivier Herault, Frédéric Mazurier
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5322–5335.
https://doi.org/10.1182/bloodadvances.2020002042
Published: 2020
Includes: Supplemental data